DRYVAX

DryVax is a technology that allows the manufacture of vaccines that have aluminum-containing adjuvants into a dosage form that is not sensitive to freezing, intentionally or unintentionally. This technology can have a profound impact on the existing vaccine supply-chain because cold-chain storage accounts for up to 80% of the financial cost of vaccination, and an estimated 75-100% of the vaccine shipments are exposed to freezing temperatures resulting in costly waste and the loss of nearly half of all global vaccine supplies. This technology will also open markets that lack cold-chain storage and as a result were unreachable for broad vaccine distribution.

#SimilarOrganizations #Financial #More

DRYVAX

Industry:
Information Technology Manufacturing Medical

Address:
Austin, Texas, United States

Country:
United States

Status:
Active

Total Funding:
0


Similar Organizations

zephyr-technology-logo

Zephyr Technology

Zephyr Technology is a manufacturer of heart rate monitors, remote physiological monitoring and wireless tele-health systems.

Investors List

texas-venture-labs_image

Texas Venture Labs

Texas Venture Labs investment in Non Equity Assistance - Dryvax

More informations about "Dryvax" on Search Engine